Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Monovalent H5N1 Vaccine in Adults
NCT00719043Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2008
- Primary completion
- Apr 2010
- Modality
- Whole Inactivated Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of influenza A (Q-Pan H5N1) virus monovalent vaccine (A/Indonesia) in Avian Influenza (AI), sponsored by GSK. Started Jul 2008; status: completed.
02
Drugs
influenza A (Q-Pan H5N1) virus monovalent vaccine (A/Indonesia)
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on NCT00719043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00719043.